Abstract
On the basis of the one strain-many compounds (OSMAC) strategy, two new cyclic thiopeptides, geninthiocins E and F, together with four known geninthiocin derivatives, geninthiocins A, B, C, and val-geninthiocin were isolated from Streptomyces sp. CPCC 200267. Their structures and absolute configurations were elucidated by extensive spectroscopic analyses and Marfey’s method. Geninthiocin E (1), val-geninthiocin (3), geninthiocin A (4), and geninthiocin B (5) exhibited significant anti-influenza A virus activities with the IC50 values of 28.7, 15.3, 7.3, and 18.3 μM, respectively. Compounds 3 and 4 showed moderate antibacterial activities against Staphylococcus aureus.
Thiopeptides are members of the ribosomally synthesized and post-translationally modified peptide family of natural products, which are widely distributed in the genera of Streptomyces, Nocardia, Micromonospora, Micrococcus, Actinoplanes, Amycolatopsis, Planobispora, and so on [1,2,3,4,5,6,7,8]. Thiopeptides are well known for their potent antibacterial activities against clinically-problematic Gram-positive pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), penicillin-resistant Streptococcus pneumonia (PRSP), and Clostridium difficile [1, 9, 10].
Thiopeptides are characterized by a highly modified macrocycle possessing a central pyridine, hydroxypyridine, or dehydropiperidine. Based on the size of macrocycle core, thiopeptides were divided into four classes: 26 atoms (thiostrepton and nosiheptide), 29 atoms (GE2270A), 32 atoms (lactazoles), and 35 atoms (berninamycins) [11, 12]. Among members of 35-atom subclasses, geninthiocins are variations on the core scaffolds via amino acid substitutions compared to berninamycins, their differences only consist in one amino acid at the genome sequence level. Our previous chemical investigation of Streptomyces sp. CPCC 203702 affforded six berninamycin analogs with excellent antiviral activities [13]. Meanwhile, three geninthiocin derivatives were isolated from Streptomyces sp. CPCC 200267 by Wu Linzhuan’s Group [12], however, the isolated geninthiocin analogs were not evaluated for their antiviral activities.
In our continuing search for antiviral thiopeptide derivatives, the one strain many compounds (OSMAC) strategy was applied to maximize the chemical diversity of strain CPCC 200267. When the strain was separately cultured by eleven medium fermentation, high performance liquid chromatography (HPLC) analyses of its culture extracts displayed different secondary metabolite profiles (Fig. S1). Subsequently, the follow-up fermentations of optional two mediums led to the isolation of six geninthiocin derivatives, including two new cyclic thiopeptides, geninthiocins E and F (1 and 2), along with four known geninthiocin analogs (3–6) (Fig. 1). Herein, we describe details of the isolation, structural elucidation, and bioactivities of all compounds.
Geninthiocin E (1) was obtained as white amorphous powder. Its molecular formula was determined as C44H43N13O12S by HRESIMS with m/z 978.29828 [M + H]+, requiring 30 degrees of unsaturation. The 1H and 13C NMR spectroscopic data (Table 1) of 1 closely resembled those of geninthiocin D [12], except for the presence of a methane (δH 2.18, δC 29.8) in 1 instead of one oxygenated non-protonated carbon (δC 71.4) in geninthiocin D, indicating the loss of the OH group in the Hyval residue. This assignment was further confirmed by the 1H–1H COSY correlations of Val-NH (δH 8.69)Val-Hα/(δH 4.40)/Val-Hβ (δH 2.18)/Val-Hγ (δH 0.96, 0.95) and the HMBC correlations of Val-Hβ (δH 2.18)/Val-Cα (δC 60.0) and Val-Cγ (δC 19.2, 18.9). The NOESY correlation (Fig. 2) between methyl protons (δH 1.73) and amide proton (δH 9.63) indicated the Z configuration of the vinyl methyl group in Oxa1 residue. The configurations of Thr and Val were established as l using Marfey’s method (Fig. S2) [14].
Geninthiocin F (2) was isolated as white amorphous powder. Its molecular formula was determined as C47H46N14O13S by HRESIMS with m/z 1047.31873 [M + H]+, which is 69 amu more than that of 1. This suggests the introduction of a Dha residue in 2 compared with 1. Comparison of 1H and 13C NMR spectroscopic data (Table 1) of 2 with those of 1 indicated that 2 displayed the additional presence of one carbonyl (δC 164.9), one double bond [δH 6.55, 5.82, δC 103.0; δC 133.7], constructing a Dha unit. The location of Dha moiety was determined by the HMBC correlations (Fig. 2) from terminal -NH2 (δH 8.14, 7.64) to Dha3-C=O (δC 164.9) and Dha3-Cα (δC 133.7), from Dha3-H2β (δH 6.55, 5.82) to Dha3-Cα (δC 133.7) and Dha3-C=O (δC 164.9), and from Dha3-NH (δH 10.63) to Pyr-C=O (δC 161.1) and Dha3-C=O (δC 164.9). The NOESY correlation (Fig. 2) between methyl protons (δH 1.74) and amide proton (δH 9.66) estblished the Z configuration of the vinyl methyl group in Oxa1 residue. The configurations of Thr and Val were determined to be l using Marfey’s method (Fig. S2) [14].
The known cyclic thiopeptides were identified as val-geninthiocin (3) [15], geninthiocin A (4) [12], geninthiocin B (5) [16], geninthiocin C (6) [12] by comparison of their NMR and MS data with those reported in the literatures.
Compounds 1–6 were evaluated for anti-influenza A virus (IAV) activities [13]. Compounds 1, 3, 4, and 5 exhibited significant anti-IAV (H1N1) activities with the IC50 values of 28.7, 15.3, 7.3, and 18.3 μM, respectively (Table 2). Compounds 1–6 were tested for antibacterial activities against Staphylococcus aureus ATCC 29213 and Escherichia coli ATCC 25922 [13]. Compound 3 and 4 displayed moderate antimicrobial activity against S. aureus ATCC 29213 with MIC of 16 and 4 μg ml–1, respectively.
In summary, two new geninthiocin derivatives, geninthiocins E (1) and F (2), together with four known geninthiocin analogs were isolated from Streptomyces sp. CPCC 200267 using OSMAC approach. Compounds 1, 3, 4, and 5 showed significant anti-IAV activities, and compounds 3 and 4 displayed moderate antibacterial activities.
References
Shen X, Mustafa M, Chen Y, Gao Y, Gao J. Natural thiopeptides as a privileged scaffold for drug discovery and therapeutic development. Med Chem Res. 2019;28:1063–98.
Kohno J, Kameda N, Nishio M, Kinumaki A, Komatsubara K. The structures of sulfomycins II and III. J Antibiot. 1996;49:1063–5.
Mukai A, Fukai T, Hoshino Y, Yazawa K, Harada KI, Mikami Y. Nocardithiocin, a novel thiopeptide antibiotic, produced by pathogenic Nocardia pseudobrasiliensis IFM 0757. J Antibiot. 2009;62:613–9.
Puar MS, Chan TM, Hegde V, Patel M, Bartner P, Ng KJ, Pramanik BN, MacFarlane RD. Sch 40832: a novel thiostrepton from Micromonospora carbonacea. J Antibiot. 1998;51:221–4.
Rogers MJ, Cundliffe E, McCutchan TF. The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite. Antimicrob Agents Chemother. 1998;42:715–6.
Zhang C, Occi J, Masurekar P, Barrett JF, Zink DL, Smith S, Onishi R, Ha S, Salazar O, Genilloud O, Basilio A, Vicente F, Gill C, Hickey EJ, Dorso K, Motyl M, Singh SB. Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347. J Am Chem Soc. 2008;130:12102–10.
Zhang C, Herath K, Jayasuriya H, Ondeyka JG, Zink DL, Occi J, Birdsall G, Venugopal J, Ushio M, Burgess B, Masurekar P, Barrett JF, Singh SB. Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa. J Nat Prod. 2009;72:841–7.
Del Carratore F, Iorio M, Pérez-Bonilla M, Schmidt K, Pérez-Redondo R, Sosio M, Macdonald SJ, Gyulev IS, Tsigkinopoulou A, Thomas GH, Genilloud O, Rodríguez-García A, Donadio S, Breitling R, Takano E. Multi-omics study of Planobispora rosea, producer of the thiopeptide antibiotic GE2270A. mSystems. 2021;6:e0034121.
Bagley MC, Dale JW, Merritt EA, Xiong X. Thiopeptide antibiotics. Chem Rev. 2005;105:685–714.
Vinogradov AA, Suga H. Introduction to thiopeptides: biological activity, biosynthesis, and strategies for functional reprogramming. Cell Chem Biol. 2020;27:1032–51.
Bowers AA, Walsh CT, Acker MG. Genetic interception and structural characterization of thiopeptide cyclization precursors from Bacillus cereus. J Am Chem Soc. 2010;132:12182–4.
Li S, Hu X, Li L, Liu H, Yu L, You X, Jiang B, Wu L. Geninthiocins C and D from Streptomyces as 35-membered macrocyclic thiopeptides with modified tail moiety. J Antibiot. 2019;72:106–10.
Zhang D, Wang Y, Hu X, Wang X, Li L, Gu G, Zhang B, Cen S, You X, Yu L. Cyclic and linear thiopeptides from soil-derived Streptomyces sp. CPCC 203702 with antiviral and antibacterial activities. Chin J Chem. 2021;39:3277–84.
Vijayasarathy S, Prasad P, Fremlin LJ, Ratnayake R, Salim AA, Khalil Z, Capon RJ. C3 and 2D C3 Marfey’s methods for amino acid analysis in natural products. J Nat Prod. 2016;79:421–7.
Sajid I, Shaaban KA, Frauendorf H, Hasnain S, Laatsch H. Val-geninthiocin: structure elucidation and MSn fragmentation of thiopeptide antibiotics produced by Streptomyces sp. RSF18 Z Naturforsch B. 2008;63b:1223–30.
Schneider O, Simic N, Aachmann FL, Aachmann FL, Rückert C, Kristiansen KA, Kalinowski J, Jiang Y, Wang L, Jiang CL, Lake R, Zotchev SB. Genome mining of Streptomyces sp. YIM 130001 isolated from lichen affords new thiopeptide antibiotic. Front Microbiol. 2018;9:3139.
Acknowledgements
The authors thank the mass spectrometry facility of National Center for Protein Sciences at Peking University and Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College for assistance with NMR spectrometer and Dr. Xiaogang Niu for help with NMR spectroscopic data analyses.
Funding
The work was financially supported by the National Natural Science Foundation of China (82073744), CAMS Innovation Fund for Medical Sciences (2021-I2M-1-055), the Non-profit Central Research Institute Fund of CAMS (2021-PT350-001), and the National Microbial Resource Center (No. NMRC-2022-3).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Fang, Y., Wang, J., Tang, Y. et al. Geninthiocins E and F, two new cyclic thiopeptides with antiviral activities from soil-derived Streptomyces sp. CPCC 200267 using OSMAC strategy. J Antibiot 76, 101–104 (2023). https://doi.org/10.1038/s41429-022-00580-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-022-00580-0